Two enzymes are considered to be unique to the photosynthetic Calvin-Benson cycle: ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO), responsible for CO 2 fixation, and phosphoribulokinase (PRK). Some archaea possess bona fide RuBisCOs, despite not being photosynthetic organisms, but are thought to lack PRK. Here we demonstrate the existence in methanogenic archaea of a carbon metabolic pathway involving RuBisCO and PRK, which we term 'reductive hexulose-phosphate' (RHP) pathway. These archaea possess both RuBisCO and a catalytically active PRK whose crystal structure resembles that of photosynthetic bacterial PRK. Capillary electrophoresis-mass spectrometric analysis of metabolites reveals that the RHP pathway, which differs from the Calvin-Benson cycle only in a few steps, is active in vivo. Our work highlights evolutionary and functional links between RuBisCOmediated carbon metabolic pathways in methanogenic archaea and photosynthetic organisms. Whether the RHP pathway allows for autotrophy (that is, growth exclusively with CO 2 as carbon source) remains unknown.
T o date, six mechanisms have been identified for carbon fixation 1 . Of these, members of Archaea are believed to be able to use three, namely dicarboxylate-hydroxybutyrate cycle, hydroxypropionate-hydroxybutyrate cycle, and reductive acetyl-CoA pathway. The reductive acetyl-CoA pathway has been discussed as a model of the primordial CO 2 -fixing mechanism 1 . The Calvin-Benson cycle is the predominant photosynthetic CO 2 -fixing pathway 2 ; however, it is considered to be an evolutionary late innovation and has not been reported in Archaea 1 . The Calvin-Benson cycle consists of three phases: carbon fixation, carbon reduction, and ribulose-1,5-bisphosphate (RuBP) regeneration. In this cycle, ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO) fixes CO 2 with RuBP to yield 3-phosphoglycerate (3-PGA), from which RuBP is regenerated 3 . Phosphoribulokinase (PRK) synthesizes RuBP from ribulose-5-phosphate (Ru5P) in the final step in RuBP regeneration 3, 4 . RuBisCO and PRK are representative and unique enzymes of the photosynthetic Calvin-Benson cycle 5 . Interestingly, approximately half of the members of archaea that have currently been sequenced have a conserved gene for bona fide RuBisCO. Nevertheless, PRK genes and PRK activity have not been detected in Archaea. An alternative pathway distinct from the Calvin-Benson cycle may thus be present in Archaea to synthesize RuBP from either 5-phospho-D-ribose-1-pyrophosphate (PRPP) or nucleoside 5 0 -monophosphate (NMP) via common ribose-1,5-bisphosphate 6, 7 . These pathways are not cyclic and cannot regenerate RuBP. The pentose bisphosphate pathway to generate RuBP as substrate for RuBisCO from nucleosides or NMP has been especially well characterized in Thermococcus kodakarensis and is thought to be involved in nucleoside assimilation and degradation [7] [8] [9] .
Here, we report a carbon metabolic pathway involving RuBisCO and PRK that can regenerate RuBP in methanogenic archaea.
Results
Enzymatic analysis of archaeal PRK homologues. Some members of the archaeal phylum Euryarchaeota, including Methanospirillum hungatei, possess conserved genes for PRK homologues, as well as RuBisCO. BLAST search with PRK of cyanobacterium Synechococcus PCC7942 against archaeal protein database identified PRK homologues in Archaea. Photosynthetic PRKs are classified into two groups from photosynthetic bacteria and plant-type oxygenic phototrophs such as plants, algae and cyanobacteria 4, 10, 11 . Archaeal PRK homologues show approximately 30% amino acid sequence identity with PRKs in photosynthetic organisms and form a clade clearly distinct from those of bacterial and plant-type PRKs in a phylogenetic tree (Fig. 1) . PRK homologue genes are conserved in 11 mesophilic methanogenic archaea ( Fig. 1; Supplementary Table 1 ). In addition to methanogenic archaea, four hyperthermophilic archaea species, including Archaeoglobus profundus placed near the base of a 16S rRNA-derived phylogenetic tree 12 , possess PRK homologue genes. In contrast, these genes are not conserved in Methanopyrus spp. and Methanocaldococcus jannaschii, both hyperthermophilic methanogenic archaea species.
Archaeal PRK homologues possess conserved Walker A (P-loop) and B motifs, which are usually involved in binding of the phosphate groups of nucleoside triphosphate and coordination of a Mg 2 þ ion, respectively ( Supplementary Fig. 1 ). These motifs are strongly conserved in P-loop kinases that recognize various substrates as phosphorylation acceptors 13 . We analysed the specificity of the M. hungatei PRK (MhPRK) homologue for the known P-loop kinase substrates pantothenate, thymidine, uridine, cytidine, ribosylnicotinamide, fructose 6-phosphate, AMP, ribose 5-phosphate and Ru5P (refs 14-19) , but found that it showed kinase activity only for Ru5P. In an electrospray tandem mass spectrometry analysis, the product of the reaction catalysed by MhPRK with Ru5P as the substrate was identified as RuBP. This identification was based on the product's peak (M-H) À at m/z 309 and a comparison of its fragmentation pattern with that of authentic RuBP ( Supplementary Fig. 2 ). MhPRK had a V max of 29.28 ± 1.70 mmol min À 1 mg protein À 1 , a K m (Ru5P) of 0.28 ± 0.05 mM and a K m (ATP) of 20.7 ± 1.7 mM (Table 1) . PRK activity was also detected in M. hungatei cell extracts (84.14 ± 8.32 nmol min À 1 mg protein À 1 ). Archaeal PRK homologues from Methanoculleus marisnigri, Methanosaeta thermophila, Methanosaeta concilii, and A. profundus also showed significant PRK activities ( Table 1 ). The V max values of the archaeal PRKs were lower than those of photosynthetic PRKs, but the archaeal PRKs showed higher affinities for ATP than did the photosynthetic PRKs (Table 1) . MhPRK utilized broad phosphate donor substrates, such as ATP, GTP, CTP and UTP. Kinase activities with CTP, UTP and GTP were respectively 74.35%, 60.48% and 93.96% of that with ATP ( Supplementary  Fig. 3 ). On the other hand, photosynthetic PRK as a phosphate donor is relatively specific to ATP (refs 20,21) .
Crystal structure of M. hungatei PRK. To structurally characterize the archaeal PRK, we determined the crystal structure of MhPRK at 2.5-Å resolution (PDB ID 5B3F). MhPRK forms a dimer with dimensions of B105 Â 50 Â 40 Å 3 (Supplementary Fig. 4a ). The two protomers within the dimer are related by approximately two-fold noncrystallographic symmetry. Each protomer consists of an eight-stranded mixed b-sheet (b1-6 and b8-9) core surrounded by several a-helices (a1-a9) and b-strands (b1 0 , b2 0 and b7; Fig. 2a,c ). This protomer structure is similar to that of the only photosynthetic PRK whose structure has been reported to date 22 , that of photosynthetic bacterial PRK from Rhodobacter sphaeroides (RsPRK; PDB ID 1A7J; r. m. s. ds of 2.1 Å over 164 topologically equivalent Ca positions of MhPRK and RsPRK) (Fig. 2a-d and Supplementary Fig. 5 ). This structural similarity of MhPRK and RsPRK is in spite of their low amino acid sequence identity (25%). Conversely, MhPRK (homodimer) and RsPRK (homooctamer) differ in their quaternary structures and manner of dimerization ( Supplementary Fig. 4 ). In dimeric MhPRK, the central strands b7, which consolidates the formation of the dimer with the larger dimer interface (1694.6 Å 2 ), and b8 form the dimer interface. In RsPRK, strands b5, 6 and 9 and a-helix 6 participate in the formation of the dimer interface, and a-helix 7 is involved in octamer formation 22 . These structures involved in dimer and octamer formation are placed in the C-terminal domain. The N-terminal domain of MhPRK resembles that of RsPRK, whereas the C-terminal domain (199-319 for MhPRK) is relatively different ( Supplementary  Fig. 1 ). Therefore, a low similarity in the C-terminal domain between MhPRK and RsPRK is consistent with differences in the manner of dimerization and quaternary structure of the two, which may lead to different enzymatic properties such as allosteric regulation of RsPRK (refs 23,24) , and not MhPRK by NADH and AMP.
Two sulphate ions are positioned at the active site of the N-terminal domain at the edge of the dimer in MhPRK ( Fig. 2c ; Supplementary Figs 4a and 6 ). One interacts with Arg59, Arg62, Tyr98 and His100 side chains, and the other interacts with the main-chain amides of residues 27-31 in the P-loop along with a water molecule that interacts with the side chains of Ser31 and Thr32 ( Fig. 2e; Supplementary Fig. 7a,c) . Except for Arg62, these residues are highly conserved in all PRKs; they are responsible for binding of the phosphate group on Ru5P or ATP ( Supplementary Fig. 1 ), as shown by the X-ray structure of the protein complexed with one sulphate ion in the binding site for the phosphate group on Ru5P, as well as mutagenesis studies of RsPRK ( Fig. 2f ; Supplementary Fig. 7b,d ) [25] [26] [27] [28] [29] . Mutagenesis and structural studies on RsPRK have also identified other residues responsible for Ru5P binding (His45 and Lys165) and ATP binding (Arg168). These residues are also structurally and sequentially conserved in MhPRK (His55, Lys151 and Arg154; Fig. 2e ,f; Supplementary  Figs 1 and 7) . These biochemical and structural analyses demonstrate that M. hungatei and other archaea possess PRKs.
Bona fide RuBisCO in M. hungatei. RuBisCOs can be classified into three forms (Fig. 3) : forms I and II are involved in the Calvin-Benson cycle in photosynthetic organisms 30, 31 , while form III is associated with the pentose bisphosphate pathway/ PRPP metabolism in members of the Archaea lacking PRK (ref. 7). M. hungatei RuBisCO was found to have a specific activity for the carboxylase reaction of 0.146±0.022 mmol min À 1 mg protein À 1 . M. hungatei thus has two key enzymes in the Calvin-Benson cycle. The RuBisCO of M. hungatei forms a new clade together with RuBisCOs from other methanogenic archaea harbouring PRK; this clade is distinct from the form-III RuBisCOs in the phylogenetic tree (Fig. 3) . Archaeal form-III RuBisCOs should therefore be categorized into two groups: form III-a in mainly methanogenic archaea and form III-b in other archaea. Methanogenic archaea possessing form III-a RuBisCO also have PRK. The placement of some methanogenic archaeal RuBisCOs in the form-II clade of photosynthetic bacteria reveals the evolutionary intersection between nonphotosynthetic and photosynthetic organisms with respect to RuBisCO. On the other hand, archaeal PRK forms a clade that is clearly separated from bacterial and plant-type clades ( Fig. 1) , which suggests that the molecular evolution of RuBisCO and PRK has been different.
A carbon metabolic pathway involving RuBisCO. The coexistence of PRK and RuBisCO indicated that CO 2 fixation might exist in M. hungatei. However, genes encoding three other Calvin-Benson cycle enzymes-transketolase, sedoheptulose-1,7-bisphosphatase, and ribulose-5-phosphate 3-epimerase-that catalyse the steps from fructose-6-phosphate (F6P) to Ru5P are missing from this archaeon, as they are from most members of the Archaea. In general, Archaea do not possess genes for transketolase and transaldolase needed for the non-oxidative pentose phosphate pathway 32, 33 ; instead, aromatic amino acids are synthesized via chorismate and shikimate in the 6-deoxy-5-ketofructose-1-phosphate pathway 34 . Archaea may synthesize Ru5P from F6P via the ribulose monophosphate (RuMP) pathway operating in the reverse direction 33, 35 . In the RuMP pathway, formaldehyde is fixed with Ru5P to form D-arabino-3-hexulose-6-phosphate (Hu6P) by D-arabino-3-hexulose-6-phosphate synthase (HPS) and then isomerized to F6P by 6-phospho-3-hexuloisomerase (PHI) 36 . Both enzymes catalyse reversible reactions. M. hungatei has four candidate genes for the RuMP pathway. Two candidate HPSs are fusion proteins: Mhun0647 (HPS-MenG) is a fusion of HPS and a domain similar to demethylmenaquinone methyltransferase (MenG) 37 , whereas Mhun1628 (Fae-HPS) is a fusion of HPS and formaldehydeactivating enzyme (Fae) 35 , which catalyses the condensation of formaldehyde with tetrahydromethanopterin. MenG catalyses the last step in menaquinone biosynthesis, but the function of the MenG-like domain in HPS-MenG is unknown. HPS-MenG and Fae-HPS showed specific activities of 0.21 ± 0.05 and 6.05±1.64 mmol min À 1 mg protein À 1 , respectively (Supplementary Table 2 ). Two putative PHIs, Mhun0910 and Mhun3031, named PHI-a and PHI-b in this report, jointly showed PHI activity (0.71 ± 0.17 mmol min À 1 mg protein À 1 ). However, there was no activity with PHI-a or -b alone (Supplementary Table 2 ), suggesting that PHI-a and -b catalyse the isomerase reaction in concert. We therefore concluded that these reaction steps were catalysed at biologically reasonable rates by HPS, PHI-a and PHI-b. These results suggest that RuBP is regenerated from F6P via Hu6P by PHI-a and PHI-b, HPS-MenG/Fae-HPS and PRK, to serve as the substrate for RuBisCO in M. hungatei. This pathway might be cyclized by gluconeogenesis enzymes. Therefore, we propose that a carbon metabolic pathway involving RuBisCO and PRK exists in some methanogenic archaea, similar to the photosynthetic Calvin-Benson cycle. We term this pathway the 'reductive hexulose-phosphate' (RHP) pathway (Fig. 4) . In extracts of M. hungatei, 3-PGA was produced from RuBP ( Fig. 5a ). In contrast, no 3-PGA was produced in the presence of 2-carboxy-D-arabinitol-1,5-bisphosphate (CABP), a RuBisCOspecific transition state inhibitor 38 . The fact that CABP completely inhibited the conversion of F6P into 3-PGA in M. hungatei extracts (Fig. 5b) shows that this conversion is RuBisCO-dependent.
To analyse the RHP pathway in vivo, a metabolomic analysis was performed with 13 C-labelling from NaH 13 CO 3 and M. hungatei living cells under heterotrophic conditions. Capillary electrophoresis-mass spectrometry (CE-MS) was used to analyse the 13 C-labelling rate of compounds. Intracellular metabolites were extracted and analysed by CE-MS after 13 C labelling for 1, 3, 5 and 10 min to access metabolic turnover. The ratio of 13 C to total carbon in each metabolite, the 13 C-fraction (%), was calculated from mass isotopomer distributions. The 13 C-fraction associated with sugar phosphates involved in the RHP pathway, gluconeogenesis and glycolysis increased linearly depending on time, with particularly high 13 C-labelling rates observed for 3-PGA, fructose-1,6-bisphosphate (FBP), F6P, glucose-6-phosphate (G6P), 2-phosphoglycerate (2-PGA) and phosphoenolpyruvate (PEP) ( Fig. 6; Supplementary Fig. 8 ). Considering that the RuBisCO was active in extracts and labelling rate and pool size of 3-PGA were high ( Supplementary Fig. 9 ), 3-PGA was expected to be the first major compound with incorporated 13 CO 2 in M. hungatei. On the other hand, 13 C atoms were incorporated into acetyl-CoA at a low rate, but hardly into pyruvate, which suggests that the reductive acetylCoA pathway worked slowly and that the carbon flow from acetyl-CoA to 3-PGA via pyruvate, PEP, and 2-PGA did not play a major role in 13 C atom incorporation into 3-PGA under our experimental conditions. These results support the idea that incorporation of 13 C atoms into 3-PGA mainly stemmed from the carboxylase reaction of RuBisCO. Among the intermediates of the RHP pathway, FBP and F6P showed high 13 C labelling rates and Ru5P showed a significant, albeit lower, one, strongly suggesting that this pathway was active in M. hungatei. The 13 C labelling was not detected in RuBP, glyceraldehyde-3-phosphate (GAP), and dihydroxyacetone phosphate (DHAP) because the original pool sizes of these unlabelled metabolites were very low ( Supplementary Fig. 9) . A large proportion of the 13 C atoms incorporated into 3-PGA were effluxed from the RHP pathway through F6P and 3-PGA to gluconeogenesis and glycolysis, respectively. The metabolic flow of glycolysis from 3-PGA to PEP via 2-PGA was clearly detected but that from PEP to acetyl-CoA via pyruvate was not, because time course of the 13 C-fraction were largely different between PEP and pyruvate. The metabolic flow of gluconeogenesis, from F6P to G6P and G1P was observed. These results suggest that a large proportion of carbons fixed by RuBisCO were supplied to gluconeogenesis and glycolysis, and a small part of these were recycled for RuBP regeneration in the RHP pathway.
Discussion
The results of our in vitro and in vivo experiments support the idea that RuBisCO and PRK function in the RHP pathway to fix CO 2 . In addition, we found that this pathway was the major mode of CO 2 fixation in M. hungatei under our experimental heterotrophic conditions. However, the 13 C-atom labelling rate was much lower and the pool size of 3-PGA much smaller compared with observations in photosynthetic organisms 39, 40 . This suggests that investment of energy in the RHP pathway is much smaller compared with that invested by plants and cyanobacteria in the Calvin-Benson cycle. Methanogenic archaea carry out methanogenesis with a low energy output compared with photosystems in photosynthesis, which is consistent with the observation that M. hungatei RuBisCO and PRK activities were much lower than those of photosynthetic organisms (Table 1 ). In the regeneration of RuBP during the RHP pathway, carbon is fixed as formaldehyde; one molecule of CO 2 is reduced to one molecule of formaldehyde using three molecules of ATP and two molecules of NAD(P)H (Fig. 4) . Considering that methanogenic archaea thrive under extreme energy limitation, RuBP regeneration may incur a high energy cost for these species. The energy yield of methanogenesis under standard conditions is estimated to be 131 kJ mol À 1 of methane produced. Under ecological conditions of 1-10 Pa H 2 , the energy yield is lower at 15-35 kJ mol À 1 and this is insufficient for the synthesis of 1 mol of ATP per 1 mol of methane produced 41 . Methanogenesis coupled with ATP synthesis depends on substrate H 2 concentrations 42 . Therefore, RuBP regeneration can probably work under conditions where methanogenesis is sufficiently active to produce enough energy for the RHP pathway and other pathways essential for growth. Our experimental conditions included high hydrogen and CO 2 concentrations, which should sustain active methanogenesis. In addition, a heterotrophic medium containing formate, acetate, yeast extract and trypticase peptone was used for culture. Although M. hungatei can grow under autotrophic and heterotrophic conditions 43 , a heterotrophic medium has been established for a suitable pure culture of M. hungatei in laboratories and enables to grow with higher rate than autotrophic medium. These heterotrophic conditions might also provide energy for the RHP pathway. Whether the RHP pathway allows for autotrophy, that is, growth exclusively with CO 2 as carbon source, is unknown at present.
CE-MS analysis showed that a large proportion of the carbon fixed by RuBisCO flowed to gluconeogenesis and glycolysis, and that a small fraction of this carbon was released as formaldehyde in RuBP regeneration (Fig. 6 ). This suggests that the metabolic flux of RuBP regeneration in the RHP pathway was small and required relatively low energy, which can be sustained by energy obtained from methanogenesis. However, the energetics of the RHP pathway in methanogenic archaea under ecological conditions remains to be addressed further.
The RHP pathway supplies fixed carbon to other important metabolic pathways. CE-MS analysis showed that the RHP pathway provides a large proportion of fixed carbon to gluconeogenesis and glycolysis via F6P and 3-PGA. The RHP pathway also provides Ru5P, which is isomerized to ribose-5-phosphate before use, for nucleotide biosynthesis (Fig. 6) . Production of Ru5P is likely to be completely dependent on the RHP pathway (Fig. 4) Table 1 ), suggesting that RuBP may be provided by both the RHP pathway and the pentose bisphosphate pathway (Fig. 4) . The heterotrophic medium used in our experiments provides nucleosides and NMP for the anaplerotic pentose bisphosphate pathway, to supply RuBP to the RHP pathway, as previously reported in Thermococcus kodakaraensis 9 . Hence, the pentose bisphosphate pathway may act as an anaplerotic pathway for the RHP pathway under our experimental conditions. Formaldehyde released from the RHP pathway can be condensed by Fae with tetrahydromethanopterin to form methylene tetrahydromethanopterin, an intermediate in both the reductive acetyl-CoA pathway and methanogenesis for energy production, another pathway for CO 2 fixation (Fig. 4) 1,41,44 . The M. hungatei HPS is fused to Fae, which might immediately capture formaldehyde 35 . Archaea that have genes for the RHP pathway (except Aciduliprofundum boonei) either possess homologous genes for HPS and Fae (for example, in Ferroglobus placidus, Methanosaeta harundinacea, M. concilii and M. marisnigri) or have a gene that encodes a fused HSP/Fae protein (in other 10 species), similar to M. hungatei (Supplementary Table 1 ). Almost all archaea harbouring the RHP pathway possess a conserved Fae/HPS fusion protein (Supplementary Table 1 ). The fact that HPS and Fae are fused indicates that Fae might recover formaldehyde released from the RHP pathway and supply it to the reductive acetyl-CoA pathway and methanogenesis (Fig. 4) . The fusion of HPS and Fae might minimize carbon loss and supply reduced carbon to the reductive acetyl-CoA pathway and methanogenesis. The CE-MS data showed that acetyl-CoA was not converted to 3-PGA via pyruvate ferredoxin oxidoreductase, phosphoenolpyruvate synthase, phosphopyruvate hydratase, and phosphoglycerate mutase (Fig. 6) . Therefore, it is expected that formaldehyde is incorporated into acetyl-CoA in the reductive acetyl-CoA pathway and then converted to lipid via the mevalonate pathway, which is the archaeal isoprenoid biosynthetic pathway 45 . Nevertheless, the metabolomic analysis used in our study could not follow carbon from formaldehyde to methane and acetyl-CoA. To clarify these issues, a metabolomic analysis system specific for metabolites produced by these pathways will need to be established. Many methanogenic archaea contain conserved genes for enzymes in the RHP pathway, including RuBisCO and PRK, and for the reductive acetyl-CoA pathway (Supplementary Table 1 ). These pathways are thus expected to be widely distributed in methanogenic archaea. Hyperthermophilic archaea of the genera Archaeoglobus and Ferroglobus also contain genes for RHP pathway enzymes (Supplementary Table 1 ). These archaea also have conserved genes for methanogenesis; they can produce trace C fraction (%) 13 C fraction (%) 13 C fraction (%) 13 C fraction (%) 13 C fraction (%) 13 C fraction (%) 13 C fraction (%) 13 C fraction (%) 13 C fraction (%) 13 C fraction (%) 13 C fraction (%) Figure 6 | Time-course analysis of the metabolite 13 C fraction of M. hungatei cells. The y axis represents the ratio of 13 amounts of methane 46 and have a reductive acetyl-CoA pathway 1 . This indicates that a metabolic link exists between the RHP pathway and the methanogenesis/reductive acetyl-CoA pathway. Evolutionary acquisition of the photosynthetic Calvin-Benson cycle has had a major impact on the global carbon cycle 47 . The RHP pathway and the Calvin-Benson cycle only differ in a few steps, namely from F6P to Ru5P. Thus, our results shed light on evolutionary and functional links between carbon metabolic pathways involving RuBisCO in methanogenic archaea and photosynthetic organisms. We speculate that the photosynthetic Calvin-Benson cycle may have originated from a primitive carbon metabolic pathway utilizing RuBisCO, such as the archaeal RHP pathway, by replacement of some steps without release of carbon.
Methods
Multiple sequence alignment and phylogenetic analyses. Amino acid sequences were aligned with Genetyx ver. 11, followed by manual adjustment. Phylogenetic analyses were conducted using the neighbour-joining (NJ) method with Genetyx ver. 11. Bootstrap values were inferred from 1,000 replicates. Trees were constructed using Genetyx-tree. Preparation of recombinant proteins. Expression plasmids for the His 6 -tagged M. hungatei PRK homologue and RuBisCO recombinant proteins were constructed as follows. Template genomic DNA was prepared from M. hungatei cells with a DNA plant mini kit (Qiagen, Japan). We used the Escherichia coli DH5a strain and the vector pET15b (Novagen: Merck, Japan) for cloning. A DNA fragment containing the gene encoding the PRK homologue (Mhun0794) with 5 0 -XhoI and 3 0 -NdeI sites, or RuBisCO (Mhun2315) with 5 0 -XhoI and 3 0 -BamHI sites, was amplified by polymerase chain reaction (PCR) with PrimeSTAR Max DNA polymerase (Takara, Japan) and the primer set Mhprk-F and R, or Mhrubisco-F and R (Supplementary Table 3 ), respectively, using M. hungatei genomic DNA as the template. After digestion with restriction enzymes, the fragments were inserted into pET-15b (Novagen) digested with the same restriction enzymes, resulting in the plasmids pET-Mhprk and pET-Mhrubisco. E. coli C43 (DE3) (Lucigen, WI, USA) was used to overexpress the M. hungatei PRK homologue and RuBisCO. Cells of E. coli were grown at 37°C in LB medium containing 50 mg ml À 1 ampicillin until their optical density at 600 nm reached 0.4-0.6. Then, gene expression was induced by adding 1 mM b-isopropyl-D-thiogalactopyranoside and culturing the cells for 20 h at 18°C. The cells were harvested by centrifugation (5,000g, 15 min) .
Harvested cells were suspended in binding buffer (20 mM Tris-HCl, 500 mM NaCl, 5 mM imidazole, pH 8.0) and disrupted by sonication. The crude extracts were centrifuged at 20,000g for 15 min. The supernatant was applied to His-Bind resin (Novagen) equilibrated with binding buffer. The column was washed with binding buffer and wash buffer (20 mM Tris-HCl, 500 mM NaCl and 60 mM imidazole, pH 8.0), and then Mh-PRK and Mh-RuBisCO were eluted with elution buffer (20 mM Tris-HCl, 500 mM NaCl and 1 M imidazole, pH 8.0). Eluted samples were concentrated using an Amicon Ultra-10 K membrane concentrator (Merck Millipore, Japan). The buffer was exchanged with thrombin buffer (20 mM Tris-HCl, 150 mM NaCl, and 2.5 mM CaCl 2 , pH 8.0) by using a PD-10 column (GE Healthcare, Japan). His-tagged Mh-PRK and Mh-RuBisCO were cleaved for 3 h at 25°C with 2 units thrombin protease (Novagen). The His-tag and thrombin were removed by gel filtration on a Superose 6 10/300 GL column (GE Healthcare) eluted with gel filtration buffer (50 mM Tris-HCl, 0.5 mM EDTA and 100 mM KCl, pH 8.0).
To prepare the four other archaeal PRK homologues, expression plasmids for the His 6 -tagged recombinant proteins were constructed as follows. Table 3 ), respectively. These DNA fragments with 5 0 -XhoI and 3 0 -BamHI sites were inserted into the pET15b vector (Novagen) using an In-Fusion HD Cloning Kit (Takara-Clontech, Japan). The PRK homologues were overexpressed in E. coli C43 (DE3) cells. Induction of gene expression and purification of recombinant proteins were performed using the same procedure as that used for MhPRK.
Expression plasmids for His 6 -tagged M. hungatei HPS and PHI recombinant proteins were constructed as follows. DNA fragments containing genes encoding HPSs (Mhun0647 encoding MhHPS-MenG and Mhun1628 encoding MhFae-HPS) and PHIs (Mhun0910 encoding MhPHI-a and Mhun3031 encoding MhPHI-b) were amplified from M. hungatei genomic DNA by PCR with the following primer sets: Mhhpsmeng-F and R, Mhfaehps-F and R, Mhphi-a-F and R, and Mhphi-b-F and R (Supplementary Table 3) , respectively. These DNA fragments with 5 0 -XhoI and 3
0 -BamHI sites were inserted into the pColdI vector (Novagen) using an In-Fusion HD Cloning kit (Takara-Clontech). The recombinant proteins were overexpressed in E. coli C43 (DE3). Cells of E. coli were grown at 37°C in LB medium containing 50 mg ml À 1 ampicillin until their optical density at 600 nm reached 0.4-0.6, and then gene expression was induced by adding 1 mM IPTG following a temperature downshift to 15°C and cultivation at 15°C for 24 h. After His-tag purification, eluted samples were concentrated using an Amicon Ultra-10 K membrane concentrator (Merck Millipore). Buffer exchange with 50 mM Tris-HCl (pH 8.0) was carried out using a PD-10 column (GE Healthcare).
PRK activity assay. PRK activity was assayed at 25°C with a procedure for a cyanobacterial PRK reported previously 49 , with modifications. The reaction mixture (500 ml) contained 100 mM Tris-HCl (pH 8.0), 100 mM KCl, 10 mM MgCl 2 , 0.2 mM NADH, 2 mM ATP, 2.5 mM phospho(enol)pyruvate, 2 mM Ru5P, 2.5 units L-lactate dehydrogenase (rabbit muscle, Oriental Yeast, Japan), 1 unit pyruvate kinase (rabbit muscle, Oriental Yeast) and purified enzyme. The reaction was initiated by adding the purified enzyme, and the absorbance at 340 nm was monitored with a U3300 spectrophotometer (Hitachi, Japan). Activity was calculated from the molecular extinction coefficient of NADH (6.22 Â 10 3 M À 1 cm À 1 at 340 nm). V max and K m values were determined from a Lineweaver-Burk plot.
In the assay for substrate specificity of M. hungatei PRK, Ru5P was replaced with the following substrates for P-loop kinases: 6 mM pantothenate, 2 mM thymidine, 2 mM uridine, 2 mM cytidine, 2 mM ribosylnicotinamide, 2 mM fructose 6-phosphate, 2 mM AMP or 2 mM ribose 5-phosphate. Substrate concentrations were selected based on the results of previous studies [14] [15] [16] [17] [18] [19] .
In the assay for phosphate donor specificity of M. hungatei PRK, ATP was replaced with the following substrates: 2 mM CTP, 2 mM UTP or 2 mM GTP (refs 20,21) .
RuBisCO enzyme assay. The carboxylase activity of RuBisCO was measured at 25°C using a procedure modified from Pearce and Andrews 50 . Before the assay, M. hungatei RuBisCO was activated by pre-incubation at 37°C for 30 min in 200 mM HEPES-KOH (pH 8.0) containing 20 mM MgCl 2 and 20 mM NaHCO 3 . The assay mixture (500 ml) contained 200 mM HEPES-KOH (pH 8.0), 20 mM MgCl 2 , 0.2 mM NADH, 5 mM ATP, 20 mM creatine phosphate, 50 mM NaHCO 3 , 2 mM RuBP, 11.25 units 3-phosphoglycerate kinase (yeast, Sigma-Aldrich, Japan), 10 units glyceraldehyde-3-phosphate dehydrogenase (rabbit muscle, SigmaAldrich), 12.5 units creatine phosphate kinase (rabbit muscle, Oriental Yeast) and 0.05 mg carbonic anhydrase (bovine, Sigma-Aldrich). The assay mixture also included 0.05 units protocatechuate 3,4-dioxygenase (Pseudomonas sp.; Toyobo, Japan) and 4 mM protocatechuate to remove oxygen. All buffers were pre-sparged with N 2 and assays were carried out in septum-capped cuvettes with the headspace flushed with N 2 to generate anaerobic conditions. The reaction was initiated by adding RuBP, and absorbance at 340 nm was monitored with a U3300 spectrophotometer. Activity was calculated from the molecular extinction coefficient of NADH.
HPS and PHI activity assays. HPS and PHI activities were measured at 35°C using the method of Arfman 51 with modifications. These assays monitored the forward reactions, that is, synthesis toward F6P from Ru5P and formaldehyde. The reaction mixture (500 ml) included 50 mM Tris-HCl (pH 8.0), 5 mM MgCl 2 , 0.5 mM NADP þ , 5 mM Ru5P, 0.5 units glucose-6-phosphate dehydrogenase (yeast, Oriental Yeast), 0.5 units phosphoglucose isomerase (yeast, MP Biomedicals, Germany), 5 mM formaldehyde and purified recombinant enzyme(s).
The reaction was initiated by adding formaldehyde, and absorbance at 340 nm was monitored with a U3300 spectrophotometer. Activity was calculated from the molecular extinction coefficient of NADH. Both HPS and PHI were required in the assay. Therefore, the overall coupling reaction was limited by the amounts of the two enzymes under all reaction conditions. Mass spectrometric analysis. The PRK reaction mixture (1 ml) comprised 50 mM phosphate buffer (pH 8.0), 10 mM MgCl 2 , 2 mM ATP, 2 mM Ru5P and purified enzyme. The reaction was performed at 37°C for 60 min, and was terminated by removing enzymes with an Amicon Ultra-0.5 (3 K) centrifugal filter (Merck Millipore). The sample was mixed with methanol to a final concentration of 50% and injected into a Q-TOF Ultima API (Waters, MA, USA) equipped with a nanoflow probe tip (Waters). Spectra were acquired in the negative ion mode in the 50-550 Da mass range. For acquisition of tandem mass spectra, a collision energy of 15 kV was used to induce fragmentation.
Crystallization and data collection. MhPRK was expressed in BL21 (DE3) pLysS cells (Novagen), and was purified using Ni-NTA affinity chromatography and gel filtration. Selenomethionine-labelled MhPRK was expressed in B834 (DE3) cells (Novagen) grown in minimal media supplemented with amino acids and selenomethionine, and was purified using a similar protocol as for the native MhPRK. Purified MhPRK and SeMet MhPRK samples were each concentrated to 10 mg ml À 1 . The MhPRK crystals used for X-ray diffraction were grown in 4-ml solutions that contained 2 ml protein solution and 2 ml reservoir solution (20% (w/v) polyethylene glycol 4,000, 0.2 M lithium sulphate, 0.1 M HEPES sodium, pH 7.8), equilibrated against 0.5 ml reservoir solution using the hanging-drop vapour-diffusion method at 20°C. SeMet-MhPRK crystals used for X-ray diffraction were grown in 2-ml solutions containing 1 ml protein solution and 1 ml reservoir solution (1.5 M ammonium sulphate, 12% (v/v) glycerol, 0.1 M Tris-HCl, pH 8.5), equilibrated against 0.5 ml reservoir solution using the hanging-drop vapour-diffusion method at 20°C. For both proteins, the crystal that diffracted to the highest resolution was obtained by stirring the crystallization solution 52 . Crystals were each mounted into a loop, and then flash frozen in a stream of nitrogen at 100 K. Diffraction data were collected at 100 K synchrotron radiation at the SPring8 BL44XU (Japan). The diffraction datasets were processed using HKL2000 (ref. 53) . Data collection statistics are summarized in Supplementary  Table 4 .
Structure determination and refinement. The MhPRK structure was solved using single-wavelength anomalous diffraction of a SeMet-MhPRK crystal. The structure was refined to 2.5-Å resolution and had R and R free factors of 22.2 and 28.0%, respectively (Supplementary Table 4 ). The crystallographic asymmetric unit contains two MhPRK protomers (chains A and B). The disordered regions for chain A are the His-tag and residues 1-5, 156-163 and 320-323, while those for chain B are the His-tag and residues 1-3, 156-163 and 320-323. The final model contains 614 amino acid residues and 149 water molecules.
The structure was solved using experimental phases calculated from a single anomalous dispersion experiment. Eighteen possible selenium atoms in an asymmetric unit were found by SHELXD (ref. 54) using the anomalous signals in the SeMet-MhPRK datasets. Initial phases for SeMet-MhPRK were calculated and refined using SHELXE 54 Enzyme assay in cell crude extract. M. hungatei cells cultivated in JCM 242 medium for 2 weeks were harvested by centrifugation (5,000g, 30 min, 4°C) and cryopreserved at À 20°C. Cells were lysed in 50 mM Tris-HCl (pH 7.5) containing 1 mM EDTA, 2 mM DTT, and protease inhibitor cocktail (Roche Diagnostics, Japan), and disrupted by sonication. The supernatant after centrifugation (20,000g, 30 min, 4°C) was used as the crude protein extract. The PRK activity in the crude proteins was measured as described above.
Conversion of RuBP or F6P to PGA in extracts was assayed at 37°C using a modified Sulpice assay 62 . To preactivate RuBisCO, extracts were incubated at 30°C for 20 min in 100 mM HEPES-KOH (pH 8.0), 5 mM MgCl 2 , and 50 mM NaHCO 3 . The treated extract (145 ml) was added to a pre-reaction mixture containing 80 mM HEPES-KOH (pH 8.0), 15 mM MgCl 2 , 50 mM NaHCO 3 , 0.05 mg carbonic anhydrase (Sigma-Aldrich), 0.05 units protocatechuate 3,4-dioxygenase (Toyobo), 4 mM protocatechuate, and 5 mM RuBP or F6P in a final volume of 300 ml. The pre-reaction was stopped after 2 h by adding 300 ml 80% (v/v) ethanol. The reaction was initiated by adding 160 ml pre-reacted mixture to 400 ml determination mixture (100 mM HEPES-KOH (pH 8.0), 1.5 mM MgCl 2 , 0.2 mM NADH, 5 mM ATP, 22.5 units ml À 1 PGK (Sigma-Aldrich), 20 units ml À 1 GAPDH (Sigma-Aldrich), 2 units ml À 1 TPI (Sigma-Aldrich), 1.5 units ml À 1 G3PDH (Toyobo) and 20 units ml À 1 G3POX (Toyobo)). The reaction was immediately and continuously monitored by measuring the absorbance at 340 nm with a U3300 spectrophotometer. To inactivate RuBisCO, CABP was added to extracts at a final concentration of 0.6 mM and then extracts were incubated at 30°C for 10 min before the reaction. The enzyme activities and amounts of 3-PGA production were calculated from the molecular extinction coefficient of NADH.
CE-MS analysis of 13 C-labelled M. hungatei metabolites. In vivo 13 C-labelling was performed using NaH 13 CO 3 (Cambridge Isotope Laboratories, MA, USA) as the carbon source. M. hungatei cells were cultivated in JCM 242 medium for 2 weeks. Four culture vessels (a total of 120 ml of culture, corresponding to approximately 4 mg of cell dry weight) were gas-exchanged and re-pressurized at 150 kPa with 100% H 2 gas, and 2 ml of 7.5% NaH 13 CO 3 was then added. After labelling for 1, 3, 5 and 10 min, M. hungatei cells were harvested by centrifugation (10,000g, 5 min, 4°C), washed with 5 ml of ice-cold 50 mM Tris-HCl (pH 8.0), and centrifuged. Harvested cells were suspended in 1 ml of 99.7% methanol (at À 30°C) and disrupted by vortexing for 20 s. After the addition of 400 ml ice-cold H 2 O and 1 ml ice-cold chloroform, the suspension was vortexed for 30 s and then centrifuged at 4°C and 20,000g for 5 min. The supernatant was filtered through an Amicon Ultra-0.5 (3 K) centrifugal filter (Merck Millipore). Internal standards (2 ml of 4 mM L-methionine sulfone, 2 ml of 4 mM PIPES sesquisodium salt, and 2 ml of 10 mM (1 S)-( þ )-10-camphorsulfonic acid) were added to 300 ml of the filter sample, which was then chilled with liquid nitrogen and lyophilized. The capillary electrophoresis-mass spectrometric analysis was performed as described previously 40 . Dried metabolites were dissolved in 20 ml of Milli-Q water before CE/MS analysis. The CE/MS experiments were performed using an Agilent G7100 CE system, an Agilent G6224AA LC/MSD timeof-flight (TOF) system, and an Agilent 1,200 series isocratic HPLC pump equipped with a 1:100 splitter for delivery of the sheath liquid. Agilent ChemStation software for CE and MassHunter software for the Agilent TOFMS were used for system control and data acquisition, respectively.
Data availability. Atomic coordinates and structure factors for MhPRK have been deposited in the Worldwide Protein Data Bank (wwPDB; http://www.wwpdb.org) and the Protein Data Bank of Japan at the Institute for Protein Research, Osaka University (PDBj; http://www.pdbj.org/) under PDB ID 5B3F. The authors declare that all other data supporting the findings of this study are available within the article and its Supplementary Information files, or from the corresponding authors on request.
